Peptide therapy TikTok claims: what the science actually supports

What did @ojayto actually say?

In a short clip with nearly 79,000 views, @ojayto framed peptides and testosterone as competing options, calling testosterone "a synthetic hormone that shuts down your natural production" while positioning peptides as "much safer with fewer side effects" and therefore "the better option." The framing was clean and confident. Maybe a little too clean.

To be fair, the creator acknowledged that testosterone is "much more powerful" and can produce "better results." That kind of honesty is rare in optimization-content circles. But the core argument, that peptides win on a safety-to-benefit ratio, is a lot more complicated than 30 seconds allows.

Does the science back this up?

Partially. But there are real gaps in the evidence that this video glosses over entirely.

On testosterone: the claim that exogenous testosterone suppresses endogenous production is solidly established. Testosterone replacement therapy suppresses the hypothalamic-pituitary-gonadal axis, reducing luteinizing hormone and follicle-stimulating hormone, which in turn reduces natural testosterone synthesis (Bhasin et al., 2010, New England Journal of Medicine). That part is accurate.

On peptides being "safer": this is where things get muddy. The peptide category the creator is describing, things like BPC-157, TB-500, CJC-1295, ipamorelin, covers compounds with wildly different evidence bases. BPC-157 has promising animal data but essentially no completed human clinical trials. CJC-1295 and ipamorelin stimulate growth hormone release, which carries its own risk profile, including potential effects on insulin sensitivity and, in theory, proliferative risks at supraphysiologic levels. Saying these are categorically "safer" assumes a human safety dataset that largely does not exist yet.

What did they get wrong (or right)?

They got the testosterone physiology right. Calling it "synthetic" is a minor imprecision since bioidentical testosterone does exist, but the suppression mechanism is accurately described.

They got the "safer" claim wrong, or at least massively oversimplified it. Safer based on what data? For most peptides discussed in this category, long-term human safety data is sparse or nonexistent. The absence of reported harm is not the same as demonstrated safety. Absence of evidence is not evidence of absence, as Bradford Hill criteria remind us when evaluating causality in medicine.

The framing of peptides as a direct alternative to testosterone is also misleading. These compounds do different things. Growth hormone secretagogues like ipamorelin affect GH pulsatility. BPC-157 is studied for tissue repair in animal models. They are not interchangeable substitutes for testosterone in hypogonadal treatment, and presenting them as if they operate on the same playing field obscures that distinction entirely.

• Testosterone suppression by exogenous androgens: accurate and well-documented.
• Peptides being "natural chains of amino acids": technically correct but misleading in implying this makes them inherently safe.
• Peptides being categorically safer: not supported by the available human evidence base.
• Peptides as a superior alternative to testosterone: depends entirely on what condition you are actually treating.

What should you actually know?

The real conversation here is not which is "better" in the abstract. It is what you are trying to treat, and whether you have a clinical reason to treat it at all.

Testosterone therapy has a legitimate, FDA-approved indication for diagnosed hypogonadism. It has decades of safety and efficacy data behind it, including long-term cardiovascular and hematologic monitoring protocols. The risks are real and documented, which is precisely why they can be managed with proper oversight (Traish et al., 2015, Journal of Cellular Physiology).

Most peptides discussed in this content category are not FDA-approved for the uses being promoted. Many are used off-label or are available only through compounding pharmacies, which do not carry the same manufacturing and purity guarantees as approved drugs. Comparing compounded peptides to FDA-regulated testosterone is not an apples-to-apples safety comparison.

If you are considering either, the correct move is a conversation with a clinician who can assess your actual hormone levels, health history, and goals, not a 30-second TikTok take.

Is FormBlends a good place to have that conversation?

If you are curious about peptide therapy or hormone optimization, FormBlends connects you with licensed clinicians who review your health history before making any recommendations. No one here is going to tell you one category of treatment is universally better than another. That is not how medicine works, and it is not how we work either.